This is a demo store. No orders will be fulfilled.

Pritumumab (anti-Vimentin) - Primary antibody, specific to VIM, Human IgG1, OTHER of Vimentin other, OTHER of Vimentin other

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab183037
Grouped product items
SKU Size
Availability
Price Qty
Ab183037-100μg
100μg
10
$59.90
Ab183037-1mg
1mg
4
$269.90
Ab183037-5mg
5mg
1
$719.90
Ab183037-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,149.90

Basic Description

Product Name Pritumumab (anti-Vimentin) - Primary antibody, specific to VIM, Human IgG1, OTHER of Vimentin other
Synonyms CTRCT30 antibodyEpididymis luminal protein 113 antibody | FLJ36605 antibody | HEL113 antibody | VIM antibody | VIME_HUMAN antibody | Vimentin antibody | epididymis secretory sperm binding protein | FLJ36605 | VIM | Vimentin
Specifications & Purity RUO, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity VIM
Conjugation Unconjugated
Grade Animal Free, RUO
Action Type OTHER
Mechanism of action OTHER of Vimentin other
Product Description

Pritumumab (anti-Vimentin) is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab (anti-Vimentin) recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab (anti-Vimentin) can be used for glioblastoma research.
Purity
≥95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 28.3 kDa (Light Chain) & 51.2 kDa (Heavy Chain), under reducing conditions; 200.5 kDa, under non-reducing conditions.
Purification Method Protein A purified
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 499212-74-7

Associated Targets(Human)

VIM Tbio Vimentin (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Pritumumab (anti-Vimentin) (Ab183037) - Flow Cytometry
PLVX-puro-SYMX01-P08670-HEK293 cells were stained with Pritumumab (anti-Vimentin) (Ab183037) and negative control protein respectively, washed and then followed by PE and analyzed with the FACS EC₅₀ is 81.81 nM.

Pritumumab (anti-Vimentin) (Ab183037) - SEC
The purity of Pritumumab (anti-Vimentin) (Ab183037) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0708136 Certificate of Analysis Jul 11, 2024 Ab183037
ZJ24F0708135 Certificate of Analysis Jul 11, 2024 Ab183037
ZJ24F0708134 Certificate of Analysis Jul 11, 2024 Ab183037

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.